Therapeutic Use of Mesenchymal Stem Cell-Derived Exosomes: From Basic Science to Clinics

Mesenchymal stem cells (MSC) are, due to their immunosuppressive and regenerative properties, used as new therapeutic agents in cell-based therapy of inflammatory and degenerative diseases. A large number of experimental and clinical studies revealed that most of MSC-mediated beneficial effects were attributed to the effects of MSC-sourced exosomes (MSC-Exos). MSC-Exos are nano-sized extracellular vesicles that contain MSC-derived bioactive molecules (messenger RNA (mRNA), microRNAs (miRNAs)), enzymes, cytokines, chemokines, and growth factors) that modulate phenotype, function and homing of immune cells, and regulate survival and proliferation of parenchymal cells. In this review article, we emphasized current knowledge about molecular and cellular mechanisms that were responsible for MSC-Exos-based beneficial effects in experimental models and clinical trials. Additionally, we elaborated on the challenges of conventional MSC-Exos administration and proposed the use of new bioengineering and cellular modification techniques which could enhance therapeutic effects of MSC-Exos in alleviation of inflammatory and degenerative diseases.

[1]  N. Arsenijević,et al.  Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product “Exo-d-MAPPS” in Attenuation of Chronic Airway Inflammation , 2020, Analytical cellular pathology.

[2]  C. Jorgensen,et al.  Mesenchymal Stem Cell Derived Extracellular Vesicles in Aging , 2020, Frontiers in Cell and Developmental Biology.

[3]  I. Adcock,et al.  Effect of mesenchymal stem cell‐derived exosomes on the induction of mouse tolerogenic dendritic cells , 2020, Journal of cellular physiology.

[4]  N. Arsenijević,et al.  Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases , 2019, Cells.

[5]  Ai-ran Liu,et al.  Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease , 2019, Expert opinion on biological therapy.

[6]  Jae W. Lee,et al.  Mesenchymal Stem Cell–Derived Extracellular Vesicles Decrease Lung Injury in Mice , 2019, The Journal of Immunology.

[7]  Q. Shu,et al.  Differential effects of extracellular vesicles from aging and young mesenchymal stem cells in acute lung injury , 2019, Aging.

[8]  Su Lin,et al.  Pyroptosis in Liver Disease: New Insights into Disease Mechanisms , 2019, Aging and disease.

[9]  K. Rezvani,et al.  Mesenchymal stem cell-derived exosomes for clinical use , 2019, Bone Marrow Transplantation.

[10]  H. Yu,et al.  Dendritic cells and M2 macrophage play an important role in suppression of Th2-mediated inflammation by adipose stem cells-derived extracellular vesicles. , 2019, Stem cell research.

[11]  Zhong Chen,et al.  Mesenchymal stromal cells‐derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti‐apoptotic miR‐21‐5p , 2019, European journal of pharmacology.

[12]  N. Arsenijević,et al.  Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome , 2019, Cells.

[13]  F. Yeganeh,et al.  In vitro analysis of immunomodulatory effects of mesenchymal stem cell- and tumor cell -derived exosomes on recall antigen-specific responses. , 2019, International immunopharmacology.

[14]  B. Barton,et al.  Extracellular Vesicles from Wharton's Jelly Mesenchymal Stem Cells Suppress CD4 Expressing T Cells Through Transforming Growth Factor Beta and Adenosine Signaling in a Canine Model. , 2019, Stem cells and development.

[15]  H. Fan,et al.  Extracellular vesicles containing miR‐146a attenuate experimental colitis by targeting TRAF6 and IRAK1 , 2019, International immunopharmacology.

[16]  R. Or,et al.  Mesenchymal Stromal Cell-Derived Exosomes Affect mRNA Expression and Function of B-Lymphocytes , 2018, Front. Immunol..

[17]  N. Arsenijević,et al.  Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract , 2018, Therapeutic advances in gastroenterology.

[18]  Q. Shu,et al.  Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs , 2018, Stem Cell Research & Therapy.

[19]  Xin Wang,et al.  Exosomes derived from PEDF modified adipose‐derived mesenchymal stem cells ameliorate cerebral ischemia‐reperfusion injury by regulation of autophagy and apoptosis , 2018, Experimental cell research.

[20]  Shunliang Xu,et al.  Exosomes Isolated From Human Umbilical Cord Mesenchymal Stem Cells Alleviate Neuroinflammation and Reduce Amyloid-Beta Deposition by Modulating Microglial Activation in Alzheimer’s Disease , 2018, Neurochemical Research.

[21]  M. Gutiérrez-Fernández,et al.  Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis , 2018, PloS one.

[22]  Kuender D Yang,et al.  Mesenchymal stem cell exosomes as a cell-free therapy for nerve injury–induced pain in rats , 2018, Pain.

[23]  Lisheng Wang,et al.  Exosomes originating from MSCs stimulated with TGF‐β and IFN‐γ promote Treg differentiation , 2018, Journal of cellular physiology.

[24]  F. Sánchez-Margallo,et al.  The immunomodulatory activity of extracellular vesicles derived from endometrial mesenchymal stem cells on CD4+ T cells is partially mediated by TGFbeta , 2018, Journal of tissue engineering and regenerative medicine.

[25]  M. Soleimani,et al.  Immunomodulatory effects of mesenchymal stem cell–derived exosomes on experimental type‐1 autoimmune diabetes , 2018, Journal of cellular biochemistry.

[26]  A. Arsenijević,et al.  Modulation of autophagy as new approach in mesenchymal stem cell-based therapy. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  Yi Fang,et al.  miR-21 Protects Against Ischemia/Reperfusion-Induced Acute Kidney Injury by Preventing Epithelial Cell Apoptosis and Inhibiting Dendritic Cell Maturation , 2018, Front. Physiol..

[28]  Xijuan Jiang,et al.  Lipid, Protein, and MicroRNA Composition Within Mesenchymal Stem Cell-Derived Exosomes. , 2018, Cellular reprogramming.

[29]  S. Lim,et al.  Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway. , 2018, Cytotherapy.

[30]  C. Jorgensen,et al.  Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis , 2018, Theranostics.

[31]  S. Tomarev,et al.  Mesenchymal Stem Cell–Derived Small Extracellular Vesicles Promote Neuroprotection in Rodent Models of Glaucoma , 2018, Investigative ophthalmology & visual science.

[32]  L. Yin,et al.  HucMSC exosomes-delivered 14-3-3ζ enhanced autophagy via modulation of ATG16L in preventing cisplatin-induced acute kidney injury. , 2018, American journal of translational research.

[33]  M. Stojkovic,et al.  Ethical and Safety Issues of Stem Cell-Based Therapy , 2018, International journal of medical sciences.

[34]  D. Antczak,et al.  Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells , 2017, Stem Cell Research & Therapy.

[35]  Ying Lin,et al.  Mesenchymal stem cell exosomes promote immunosuppression of regulatory T cells in asthma , 2017, Experimental cell research.

[36]  Marcel Karperien,et al.  Trophic Effects of Mesenchymal Stem Cells in Tissue Regeneration. , 2017, Tissue engineering. Part B, Reviews.

[37]  Dawei Li,et al.  Exosomes from Human-Induced Pluripotent Stem Cell–Derived Mesenchymal Stromal Cells (hiPSC-MSCs) Protect Liver against Hepatic Ischemia/ Reperfusion Injury via Activating Sphingosine Kinase and Sphingosine-1-Phosphate Signaling Pathway , 2017, Cellular Physiology and Biochemistry.

[38]  N. Arsenijević,et al.  Mesenchymal stem cell‐derived factors: Immuno‐modulatory effects and therapeutic potential , 2017, BioFactors.

[39]  R. Perez-Fernandez,et al.  Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine , 2017, International journal of molecular sciences.

[40]  B. Yu,et al.  Effects of Mesenchymal Stem Cell-Derived Exosomes on Experimental Autoimmune Uveitis , 2017, Scientific Reports.

[41]  Yongmin Yan,et al.  Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Inflammatory Bowel Disease in Mice , 2017, BioMed research international.

[42]  H. Lee,et al.  MSC-derived Extracellular Vesicles Attenuate Immune Responses in Two Autoimmune Murine Models: Type 1 Diabetes and Uveoretinitis , 2017, Stem cell reports.

[43]  P. Quesenberry,et al.  Renal Regenerative Potential of Different Extracellular Vesicle Populations Derived from Bone Marrow Mesenchymal Stromal Cells , 2017, Tissue engineering. Part A.

[44]  Guodong Yang,et al.  Exosome Mediated Delivery of miR-124 Promotes Neurogenesis after Ischemia , 2017, Molecular therapy. Nucleic acids.

[45]  L. Yin,et al.  Pre-incubation with hucMSC-exosomes prevents cisplatin-induced nephrotoxicity by activating autophagy , 2017, Stem Cell Research & Therapy.

[46]  M. Pittenger,et al.  Concise Review: MSC‐Derived Exosomes for Cell‐Free Therapy , 2017, Stem cells.

[47]  S. Sangiao-Alvarellos,et al.  Effect of age on pro-inflammatory miRNAs contained in mesenchymal stem cell-derived extracellular vesicles , 2017, Scientific Reports.

[48]  T. Wynn,et al.  Mechanisms of Organ Injury and Repair by Macrophages. , 2017, Annual review of physiology.

[49]  S. Tomarev,et al.  Bone Marrow‐Derived Mesenchymal Stem Cells‐Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA‐Dependent Mechanisms , 2017, Stem cells translational medicine.

[50]  C. Xiang,et al.  Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure , 2017, Stem Cell Research & Therapy.

[51]  K. Webster,et al.  Enhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA‐21 , 2016, Stem cells translational medicine.

[52]  Wael Nassar,et al.  Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases , 2016, Biomaterials Research.

[53]  Diangeng Li,et al.  Differentially expressed microRNAs in bone marrow mesenchymal stem cell-derived microvesicles in young and older rats and their effect on tumor growth factor-β1-mediated epithelial-mesenchymal transition in HK2 cells , 2015, Stem Cell Research & Therapy.

[54]  M. Stojkovic,et al.  Mesenchymal Stem Cells: A Friend or Foe in Immune-Mediated Diseases , 2015, Stem Cell Reviews and Reports.

[55]  M. Stojkovic,et al.  Human stem cell research and regenerative medicine--present and future. , 2011, British medical bulletin.

[56]  G. Camussi,et al.  Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[57]  Alessandro Busca,et al.  Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. , 2009, Journal of the American Society of Nephrology : JASN.

[58]  F. Slack,et al.  The let-7 microRNA represses cell proliferation pathways in human cells. , 2007, Cancer research.

[59]  S. E. Jacobsen,et al.  Potential risks of bone marrow cell transplantation into infarcted hearts. , 2007, Blood.

[60]  S. Fu,et al.  TGF‐β Induces Foxp3 + T‐Regulatory Cells from CD4 + CD25 − Precursors , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[61]  Y. Yoon,et al.  Unexpected Severe Calcification After Transplantation of Bone Marrow Cells in Acute Myocardial Infarction , 2004, Circulation.

[62]  S. Sriram,et al.  TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes. , 1997, Journal of immunology.

[63]  A. Arsenijević,et al.  Molecular Mechanisms Responsible for Anti-inflammatory and Immunosuppressive Effects of Mesenchymal Stem Cell-Derived Factors. , 2019, Advances in experimental medicine and biology.

[64]  A. Arsenijević,et al.  Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases. , 2018, Advances in experimental medicine and biology.

[65]  R. Schuster,et al.  Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphate. , 2016, Journal of hepatology.